Identification of disease specific pathways using in vivo SILAC proteomics in dystrophin deficient MDX mouse

Authors

Sree Rayavarapu, George Washington University
William Coley, George Washington University
Erdinc Cakir, Children's National Medical Center, Washington, DC
Vanessa Jahnke, Children’s National Medical Center, Washington, DC
Shin'ichi Takeda, National Center of Neurology and Psychiatry, Kodaira, Tokyo, Japan
Yoshitsugu Aoki, National Center of Neurology and Psychiatry, Kodaira, Tokyo, Japan
Heather A. Gordish-Dressman, George Washington University
Jyoti K. Jaiswal, George Washington UniversityFollow
Eric P. Hoffman, George Washington UniversityFollow
Kristy J. Brown, George Washington UniversityFollow
Yetrib Hathout, George Washington UniversityFollow
Kanneboyina Nagaraju, George Washington University

Document Type

Journal Article

Publication Date

5-2013

Journal

Molecular and Cellular Proteomics

Volume

Volume 12, Issue 5

Inclusive Pages

1061-1073

Keywords

Metabolic Networks and Pathways; Muscular Dystrophy, Duchenne--metabolism; Proteome--metabolism

Comments

PMCID: PMC3650321 [Available on 2014/5/1]

APA Citation

Rayavarapu S, Coley W, Cakir E, Jahnke V, Takeda S, Aoki Y, Grodish-Dressman H, Jaiswal JK, Hoffman EP, Brown KJ, Hathout Y, Nagaraju K. (2013). Identification of disease specific pathways using in vivo SILAC proteomics in dystrophin deficient mdx mouse. Molecular and Cellular Proteomics, 12(5), 1061-1073.

Peer Reviewed

1